Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical Trial In the context of stereotactic body radiotherapy for prostate cancer, an aggressive reduction in margin size with magnetic resonance imaging guidance is associated with lower incidence of physician-scored genitourinary and gastrointestinal toxicity and of deterioration in patient-reported bowel and sexual function up to 2 yr after treatment.
https://www.europeanurology.co....m/article/S0302-2838